Among men with idiopathic osteoporosis, 2 years of treatment with recombinant human growth hormone increases bone mineral density (BMD) and bone mineral content (BMC), Swedish researchers report.
Dr. Peter Gillberg from Orebro University Hospital, and colleagues randomly assigned 29 men, 27 to 62 years of age, with idiopathic osteoporosis to continuous daily injections of growth hormone (0.4 mg/day) or intermittent growth hormone treatment (0.8 mg/day for 14 days every 3 months). The men also received daily doses of calcium and vitamin D3.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!